Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

1.47
+0.02001.38%
Volume:16.08K
Turnover:23.34K
Market Cap:2.33M
PE:-0.29
High:1.48
Open:1.44
Low:1.40
Close:1.45
52wk High:10.44
52wk Low:1.30
Shares:1.59M
Float Shares:1.52M
Volume Ratio:0.06
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.48
PE(LYR):-0.19

Loading ...

Silo Pharma Prices USD 4 Million At-the-market Private Placement of 619,965 Shares

Reuters
·
Jul 10

Silo Pharma Issues Series A-3 and A-4 Warrants Exercisable at $6.21 Per Share

Reuters
·
Jul 10

Silo Pharma - Expects $4 Mln Gross Proceeds from Offering Before Fees

THOMSON REUTERS
·
Jul 10

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-the-market Under NASDAQ Rules

THOMSON REUTERS
·
Jul 10

Silo Pharma Subsidiary Qwikagents Joins Nvidia Developer Program

Reuters
·
Jul 07

Silo Pharma Subsidiary Qwikagents Set to Advance Enterprise AI Agent Platform Through Nvidia Developer Program

THOMSON REUTERS
·
Jul 07

Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery

TIPRANKS
·
Jun 30

Silo Pharma Launches Drug-device Robustness Study for Spc-15 PTSD Nasal Spray System

Reuters
·
Jun 30

Silo Pharma - Data to Support Planned FDA Type C Meeting Request for Ind Strategy and Phase 1 Design

THOMSON REUTERS
·
Jun 30

Silo Pharma - Robustness Study to Evaluate Spc-15 Device Performance and Formulation Stability over 30 Days

THOMSON REUTERS
·
Jun 30

Silo Pharma - Engages Resyca for Robustness Study of Spc-15 Nasal Spray System

THOMSON REUTERS
·
Jun 30

Silo Pharma reports positive stability data for stress treatment SPC-15

TIPRANKS
·
Jun 23

Silo Pharma reports SPC-15 PTSD nasal spray shows nine-month stability, supports Phase 1 trial plan

Reuters
·
Jun 23

Silo Pharma Reports Positive Stability Data for Spc-15 Ptsd Treatment, Advancing Program Toward First-in-Human Clinical Trial

THOMSON REUTERS
·
Jun 23

The loneliness crisis has gotten so bad that lawmakers are ready to spend millions of dollars to fight it

Dow Jones
·
Jun 22

The loneliness crisis has gotten so bad that lawmakers are ready to spend millions of dollars to fight it

Dow Jones
·
Jun 19

Silo Pharma announces annual shareholder meeting

Reuters
·
Jun 19

Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement

MT Newswires Live
·
Jun 18

Silo Pharma regains Nasdaq compliance with minimum bid price rule

Reuters
·
Jun 18

Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
Jun 18